Oxidative Dyshomeostasis in the Mitochondria

No abstract is available for this paper.

• Publication year

  2021

• Venue

  Handbook of Oxidative Stress in Cancer: Mechanistic Aspects

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1007/978-981-15-4501-6_70-1
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin

  2020cited by this paper
• Pentathiepins: A Novel Class of Glutathione Peroxidase 1 Inhibitors that Induce Oxidative Stress, Loss of Mitochondrial Membrane Potential and Apoptosis in Human Cancer Cells

  2020cited by this paper
• Friend turned foe: A curious case of disrupted endosymbiotic homeostasis promoting the Warburg effect in sepsis.

  2020cited by this paper
• Gene therapy for the mitochondrial genome: Purging mutations, pacifying ailments.

  2019cited by this paper
• Targeting Reactive Oxygen Species in Cancer via Chinese Herbal Medicine

  2019cited by this paper
• Inflammation and Metabolism in Cancer Cell—Mitochondria Key Player

  2019cited by this paper
• Comparison of the Effect of Native 1,4-Naphthoquinones Plumbagin, Menadione, and Lawsone on Viability, Redox Status, and Mitochondrial Functions of C6 Glioblastoma Cells

  2019cited by this paper
• Mechanism of the Formation of Electronically Excited Species by Oxidative Metabolic Processes: Role of Reactive Oxygen Species

  2019cited by this paper
• Redox control in cancer development and progression.

  2018cited by this paper
• The role of mitochondria in angiogenesis

  2018cited by this paper
• Targeting of a Photosensitizer to the Mitochondrion Enhances the Potency of Photodynamic Therapy

  2018cited by this paper
• The role of peroxiredoxins in cancer

  2017cited by this paper
• Cancer nanotheranostics: Strategies, promises and impediments.

  2016cited by this paper
• Cancer prevention and therapy through the modulation of the tumor microenvironment.

  2015cited by this paper
• Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.

  2015cited by this paper
• Broad targeting of resistance to apoptosis in cancer

  2015cited by this paper
• Designing a broad-spectrum integrative approach for cancer prevention and treatment.

  2015cited by this paper
• Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?

  2014cited by this paper
• Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal

  2014cited by this paper
• Apoptosome structure, assembly, and procaspase activation.

  2013cited by this paper
• Modulation of oxidative stress as an anticancer strategy

  2013cited by this paper
• Redox regulation of cancer cell migration and invasion.

  2013cited by this paper
• Perspectives on the Role of Photodynamic Therapy in the Treatment of Pancreatic Cancer

  2012cited by this paper
• Mitochondrial Markers for Cancer: Relevance to Diagnosis, Therapy, and Prognosis and General Understanding of Malignant Disease Mechanisms

  2012cited by this paper
• Mitochondrial remodeling in cancer metabolism and survival: potential for new therapies.

  2012cited by this paper
• Cross talk between mitochondria and NADPH oxidases.

  2011cited by this paper
• Mitochondrial oxidative stress drives tumor progression and metastasis: should we use antioxidants as a key component of cancer treatment and prevention?

  2011cited by this paper
• Mitochondrial oxidative stress in cancer-associated fibroblasts drives lactate production, promoting breast cancer tumor growth

  2011cited by this paper
• Mitochondrial DNA Content Varies with Pathological Characteristics of Breast Cancer

  2011cited by this paper
• Oxidative stress and oxidative damage in chemical carcinogenesis.

  2011cited by this paper
• Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment

  2011cited by this paper
• α‐enolase: a promising therapeutic and diagnostic tumor target

  2011cited by this paper
• Reactive oxygen species in cancer

  2010cited by this paper
• Preferential killing of cancer cells with mitochondrial dysfunction by natural compounds.

  2010cited by this paper
• Aging and Mitochondrial DNA

  2010cited by this paper
• COMPARTMENTALIZED CANCER DRUG DISCOVERY TARGETING MITOCHONDRIAL Hsp90 CHAPERONES

  2009cited by this paper
• Redox-based regulation of signal transduction: principles, pitfalls, and promises.

  2008cited by this paper
• Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells.

  2008cited by this paper
• Mitochondrial dysfunction by complex II inhibition delays overall cell cycle progression via reactive oxygen species production

  2008cited by this paper
• Mitochondria are targets of photodynamic therapy

  2007cited by this paper
• Fumarate hydratase deficiency and cancer: activation of hypoxia signaling?

  2007cited by this paper
• Mitocans as anti-cancer agents targeting mitochondria: lessons from studies with vitamin E analogues, inhibitors of complex II

  2007cited by this paper
• Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network.

  2007cited by this paper
• Mitochondrial DNA mutations in human cancer

  2006cited by this paper
• The role of autophagy in cancer development and response to therapy

  2005cited by this paper
• Cyclophilin D, a Component of the Permeability Transition-Pore, Is an Apoptosis Repressor

  2004cited by this paper
• In vitro antitumor SAR of threo/cis/threo/cis/erythro bis-THF acetogenins: correlations with their inhibition of mitochondrial Complex I.

  2003cited by this paper

• No citing papers are available for this paper.